Literature DB >> 1468802

Upper airway obstruction and the Robin sequence.

R J Shprintzen, L Singer.   

Abstract

Both the etiology of Robin sequence and the mechanisms of upper airway obstruction are heterogeneous. As a result, generalizations about the care of newborns with the combination of micrognathia, cleft palate, and airway obstruction cannot be made. Management of the airway obstruction should be based on the results of direct endoscopic observation of the site of obstruction and not on the presumptive diagnosis of glossoptosis. It should not be assumed that "catch-up growth" of the mandible will occur and lead to spontaneous resolution of either the airway obstruction or the micrognathia. The presentation of the child with Pierre Robin sequence should not be the end of the diagnostic search, but rather the beginning.

Entities:  

Mesh:

Year:  1992        PMID: 1468802

Source DB:  PubMed          Journal:  Int Anesthesiol Clin        ISSN: 0020-5907


  5 in total

1.  Neonatal mandibular distraction osteogenesis.

Authors:  Roberto L Flores
Journal:  Semin Plast Surg       Date:  2014-11       Impact factor: 2.314

Review 2.  Robin sequence: from diagnosis to development of an effective management plan.

Authors:  Kelly N Evans; Kathleen C Sie; Richard A Hopper; Robin P Glass; Anne V Hing; Michael L Cunningham
Journal:  Pediatrics       Date:  2011-04-04       Impact factor: 7.124

Review 3.  Velo-cardio-facial syndrome: 30 Years of study.

Authors:  Robert J Shprintzen
Journal:  Dev Disabil Res Rev       Date:  2008

4.  Effects of open mouth and rubber dam on upper airway patency and breathing.

Authors:  Kazuhiro Iwatani; Koichiro Matsuo; Soichiro Kawase; Nina Wakimoto; Akira Taguchi; Tadashi Ogasawara
Journal:  Clin Oral Investig       Date:  2012-08-03       Impact factor: 3.573

5.  Pierre Robin Sequence: Cost-Analysis and Qualitative Assessment of 89 Patients at the Hospital for Sick Children.

Authors:  Matthew Lee; Emily S Ho; Christopher R Forrest
Journal:  Plast Surg (Oakv)       Date:  2018-04-24       Impact factor: 0.947

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.